Jesper Bøje Andersen

Activities

Activities per year 2006 2013 2015 2016 2017 2017

• 37 Lecture and oral contribution
• 8 Peer review of manuscripts
• 7 Membership in research network
• 3 Editor of Research journal
• 2 More
  • 1 Organisation of and participation in conference
  • 1 Membership in committee, council, board

Activities per year

Search results

• NAFLD

  Jesper Bøje Andersen (Invited speaker)

  24 Nov 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• ILCA: Molecular classification and key drivers of intrahepatic CCA

  Jesper Bøje Andersen (Invited speaker)

  Sep 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• Chair: Liver cancer session

  Jesper Bøje Andersen (Panel member)

  Sep 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• Riccardo Cortese memorial lecture

  Jesper Bøje Andersen (Invited speaker)

  Jul 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• Korean liver week

  Jesper Bøje Andersen (Invited speaker)

  Jun 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• BioPeople: Future of Oncology Biomarkers Seminar & Biomed

  Jesper Bøje Andersen (Panel member)

  May 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• University of Mainz, Medicine 1: Liver lunch

  Jesper Bøje Andersen (Invited speaker)

  28 Mar 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• Satorius Research Xchange Forum: Insights, Translation and Solutions

  Jesper Bøje Andersen (Invited speaker)

  21 Feb 2017 → 23 Feb 2017

  Activity: Talk or presentation types › Lecture and oral contribution

• Hepatology (Journal)

  Jesper Bøje Andersen (Member of Editorial Board)

  1 Feb 2017 → …

  Activity: Peer-review and editorial work types › Editor of Research journal › Research

• The Cancer Genome Atlas: pan-TGFb Network (External organisation)

  Jesper Bøje Andersen (Member)

  2017

  Activity: Membership types › Membership in research network

• The Cancer Genome Atlas: Tumor Molecular Pathology (TMP) Analysis Working Group (External organisation)

  Jesper Bøje Andersen (Member)

  2017

  Activity: Membership types › Membership in research network

• Liver Cancer Seminar Series

  Jesper Bøje Andersen (Invited speaker)

  1 Dec 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• European Network Study for Cholangiocarcinoma: 1st International monothematic congress in cholangiocarcinoma: Molecular pathogenesis of intrahepatic cholangiocarcinoma

  Jesper Bøje Andersen (Invited speaker)

  4 May 2016 → 6 May 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• Center for Excellence and Integrative Cancer Biology and Genomics, NIH

  Jesper Bøje Andersen (Invited speaker)

  17 Mar 2016 → 18 Mar 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• 4th Symposium on Translational Genomics with a Special Focus on Liver

  Jesper Bøje Andersen (Invited speaker)

  Mar 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• Cholangiocarcinoma Foundation Congress: Translational genomics: Application of murine models for understanding tumor heterogeneity

  Jesper Bøje Andersen (Invited speaker)

  3 Feb 2016 → 6 Feb 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• Mutagen-Brazil: Translational Research

  Jesper Bøje Andersen (Invited speaker)

  28 Jan 2016 → 30 Jan 2016

  Activity: Talk or presentation types › Lecture and oral contribution

• International Journal of Rare Diseases & Orphan Drugs (Journal)

  Jesper Bøje Andersen (Member of Editorial Board)

  2016 → …

  Activity: Peer-review and editorial work types › Editor of Research journal › Research

• Highlight from Hepatology 2015: From Chronic Hepatitis to HCC: Molecular pathogenesis and current therapy in intrahepatic cholangiocarcinoma

  Jesper Bøje Andersen (Invited speaker)

  Oct 2015

  Activity: Talk or presentation types › Lecture and oral contribution

• Molecular pathogenesis of cholangiocarcinoma

  Jesper Bøje Andersen (Lecturer)

  Oct 2015

  Activity: Talk or presentation types › Lecture and oral contribution

• Hepatobiliary cancers: Translational Genomics Directs Therapeutic Options

  Jesper Bøje Andersen (Invited speaker)

  Aug 2015

  Activity: Talk or presentation types › Lecture and oral contribution

• EU-Life: Epigenetics and Disease

  Jesper Bøje Andersen (Organizer)

  11 May 2015 → 13 May 2015

  Activity: Participating in an event - types › Organisation of and participation in conference

• European Network Study for Cholangiocarcinoma: ENS-CCA (External organisation)

  Jesper Bøje Andersen (Board member)

  Apr 2015

  Activity: Membership types › Membership in research network

• Hallas-Møller Fellowship

  Jesper Bøje Andersen (Other)

  Apr 2015

  Activity: Talk or presentation types › Lecture and oral contribution

• BRIC-Lund University Retreat

  Jesper Bøje Andersen (Speaker)

  2015

  Activity: Talk or presentation types › Lecture and oral contribution

• Nature Genetics (Journal)

  Jesper Bøje Andersen (Review editor)

  2015

  Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

• ILCA: Decoding Tumor Heterogeneity Informs Targeted Therapies in Intrahepatic Cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  4 Sep 2014

  Activity: Talk or presentation types › Lecture and oral contribution

• Molecular Classification of Cholangiocarcinoma and Therapeutic Implications

  Jesper Bøje Andersen (Invited speaker)

  9 May 2014

  Activity: Talk or presentation types › Lecture and oral contribution

• Eu-Life: Translational Working Group (External organisation)

  Jesper Bøje Andersen (Member)

  2014

  Activity: Membership types › Membership in committee, council, board

• The Cancer Genome Atlas (TCGA), Cholangiocarcinoma Analysis Working Group (External organisation)

  Jesper Bøje Andersen (Member)

  2014 → …

  Activity: Membership types › Membership in research network

• Emerging Targets in the treatment of Cholangiocarcinoma: Liver cancer seminar

  Jesper Bøje Andersen (Lecturer)

  20 Nov 2013

  Activity: Talk or presentation types › Lecture and oral contribution

• Gut, Molecular Carcinogenesis, Oncogene (Journal)

  Jesper Bøje Andersen (Review editor)

  2013

  Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

• ILCA: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  2013

  Activity: Talk or presentation types › Lecture and oral contribution

• Georgetown University, Lombardi Comprehensive Cancer Center: Emerging Genomics-based Targets in the treatment of Cholangiocarcinoma: Ruesch symposium on HCC

  Jesper Bøje Andersen (Invited speaker)

  2013

  Activity: Talk or presentation types › Lecture and oral contribution

• Bench to Bedside: New Directions for Therapy in Primary Liver Cancer: Cancer Biology Symposium

  Jesper Bøje Andersen (Invited speaker)

  2013

  Activity: Talk or presentation types › Lecture and oral contribution

• Bench to Bedside: Translational genomics identifies promising targeted therapy for cholangiocarcinoma: Humanitas Fondazione per la Ricerca Seminars

  Jesper Bøje Andersen (Lecturer)

  2013

  Activity: Talk or presentation types › Lecture and oral contribution

• The Italian chapter of the International Cholangiocarcinoma Network (External organisation)

  Jesper Bøje Andersen (Member)

  2013

  Activity: Membership types › Membership in research network

• AASLD: Genomics-Based Directions for Targeted Therapies in Cholangiocarcinoma.: Experimental Hepatocarcinogenesis

  Jesper Bøje Andersen (Speaker)

  2013

  Activity: Talk or presentation types › Lecture and oral contribution

• British Journal of Cancer; Journal of Cancer Therapeutics & Research, BMC Cancer; Cancer Research; Clinical Cancer Research; PLoS ONE (Journal)

  Jesper Bøje Andersen (Review editor)

  2012

  Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

• ILCA workshop: Signalling pathways and molecular therapies in liver cancer: Rationale for Targeted Therapies in Intrahepatic Cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  2012

  Activity: Talk or presentation types › Lecture and oral contribution

• The Hepatobiliary Cancers Foundation (CanLiv): Genomic Basis for Targeted Therapies in Cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  2012

  Activity: Talk or presentation types › Lecture and oral contribution

• Novel Therapeutic Approaches for Treatment of Primary Liver Cancer: Epigenomic-driven therapy

  Jesper Bøje Andersen (Speaker)

  2012

  Activity: Talk or presentation types › Lecture and oral contribution

• ILCA: Application of Translational Genomics for Targeted Therapy in Cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  2012

  Activity: Talk or presentation types › Lecture and oral contribution

• Gastroenterology; Liver Transplantation; Clinical Gastroenterology & Hepatology (Journal)

  Jesper Bøje Andersen (Review editor)

  2011

  Activity: Peer-review and editorial work types › Peer review of manuscripts › Research

• Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

  Jesper Bøje Andersen (Speaker)

  2011

  Activity: Talk or presentation types › Lecture and oral contribution

• ILCA: Genomic and Genetic Characterization of Human Cholangiocarcinoma Identify Therapeutic Opportunities for Tyrosine Kinase Inhibitors

  Jesper Bøje Andersen (Speaker)

  2011

  Activity: Talk or presentation types › Lecture and oral contribution

• International Liver Cancer Association (ILCA) (External organisation)

  Jesper Bøje Andersen (Member)

  2010

  Activity: Membership types › Membership in research network

• ILCA: Transcriptomic classification and survival prediction of human cholangiocarcinoma

  Jesper Bøje Andersen (Speaker)

  2010

  Activity: Talk or presentation types › Lecture and oral contribution

• ILCA: Genomic and Epigenetic-Based Prediction of Response to Zebularine Therapy in Human Liver Cancer

  Jesper Bøje Andersen (Speaker)

  2009

  Activity: Talk or presentation types › Lecture and oral contribution

• EASL: Modulation of Demethylation and Antitumor Potential of Zebularine in Liver Cancer

  Jesper Bøje Andersen (Speaker)

  2009

  Activity: Talk or presentation types › Lecture and oral contribution